Home   Site Map   About Roche   Contact Us   Help   
This is a alt text for OncologyThis is a alt text for Oncology
Clinical. Credible. Convenient.
Not a Member? Log In Forgot Password? Instant Access Code
Sign Up
»
E-mail: Password: Code:
  Remember Me Log In
»
Go
»
Main Menu
Meeting Calendar

Select a link below to view details.
Previous March 2010 Next
S M T W T F S
  1 2 3 4 5 6
7 8 9 10 11 12 13
14 15 16 17 18 19 20
21 22 23 24 25 26 27
28 29 30 31      
Oncology Clinical Trials

Oncology Clinical Trials Database
Real-time, comprehensive global Oncology clinical trials database

  • Global clinical development on a trial-by-trial basis
  • Search by any drug name
  • Search by any status and/or phase of the trial
TrialTrove™Locked Content Click
Here
 
  What is this?
 
   
 
Roche Clinical Trials
 
Recruiting A single arm open-label, phase II study of bevacizumab in combination with trastuzumab and capecitabine as first-line treatment of patients with HER2-positive locally recurrent or metastatic breast cancer
 
 
Recruiting XERAD: Open-label, phase II, randomized, comparative, multicentre trial of concurrent Whole Brain Radiation Therapy (WBRT) and capecitabine (Xeloda® ) followed by maintenance capecitabine compared with standard WBRT in breast cancer patients with newly diagnosed brain metastasis
 
 
Recruiting An open label study of the effect of Xeloda and radiotherapy on pathological response rate in patients with locally advanced rectal cancer.
 
 
Recruiting A dose-escalation study of Xeloda plus radiation therapy in pediatric patients with newly diagnosed non-disseminated, intrinsic brainstem gliomas and high grade gliomas.
 
 
Recruiting A randomized, open label study comparing the efficacy of topical corticosteroids or Bepantol in the prophylaxis of hand-foot syndrome in patients receiving oral Xeloda for treatment of metastatic breast cancer or colorectal cancer.
 
 
No longer recruiting A randomized, open-label study of the effect of different dosing regimens of Xeloda in combination with Taxotere on disease progression in patients with locally advanced and/or metastatic breast cancer
 
 
No longer recruiting A randomized, open-label study of the effect of adjuvant therapy with adriamycin plus cytoxan followed by Taxotere or Taxotere plus Xeloda on overall survival in female patients with high-risk breast cancer
 
 
No longer recruiting An open-label first-line study of Xeloda in combination with cisplatin on overall treatment response in patients with metastatic nasopharyngeal cancer
 
 
No longer recruiting A randomized, open-label study of the effect of first-line chemotherapy with Xeloda plus cisplatin versus 5-fluorouracil plus cisplatin on time to disease progression in patients with advanced or metastatic gastric cancer
 
 
No longer recruiting An open label study to evaluate the safety of Xeloda as adjuvant monotherapy in patients who have undergone surgery for colon cancer, Dukes stage C.
 
Clinical Trials Registry and Results
Visit Roche Trials for more information on completed Roche clinical studies.

ClinicalTrials.gov provides regularly updated information about federally and privately supported clinical research in human volunteers.

RocheInvestigators.com: Investigators interested in applying to participate in the U.S. arm of global development clinical trials sponsored by Hoffmann-La Roche Inc., please click the link.